“Finnish authorities have far-reaching rights to intervene in the operations of the actors in our field of business. In the exceptional situation Finland’s needs have priority,” Orion said. “Demand for the agent in question (API) is heavy around the world at the moment but unfortunately we cannot respond to the demand commensurately.”
Amneal said it is working to source the raw materials elsewhere, and is trying to get its Brookhaven, NY, manufacturing site FDA-approved to make more products, including HCQ. Amneal has said it is donating more than 6.5 million of the tablets to New York, Texas, Louisiana and hospitals across the country.
Chintu Patel said he believes the supply issues will ease up in two or three months.
“There are multiple suppliers, but worldwide demand, so people are allocating their inventory and we are in the process of qualifying more than one supplier so we can do what we can to help in this crisis situation,” he said.
